Fact CheckerSign in

NCT06869655Completed

Resistive Diaphragmatic Training vs Volumes-Oriented Spirometer In Asthmatic Parients

Resistive Diaphragmatic Training Versus Volumes Oriented Spirometry On Pulmonary Function Test And Functional Capacity In Asthmatic Patients.

Source: ClinicalTrials.gov · Last updated 11 Mar 2025

Brief summary (registry, in English)

Asthma, a chronic lung disease characterized by airway inflammation and constriction, presents ongoing challenges despite advancements in treatment. The aim of this study to deliver non-pharmacological interventions, particularly comparing resistive diaphragmatic training (RDT) and volume-oriented spirometry, to assess their efficacy in enhancing pulmonary function and functional capacity among asthmatic patients. it will compare resistive diaphragmatic training (RDT) with volume-oriented spirometry in asthmatic patients to pinpoint the superior method for enhancing lung function and daily capabilities.

Status (registry)
Completed
Study type
Interventional
Enrollment
50 (actual)
First submitted
20 Feb 2025
Start date
10 Mar 2024
Primary completion date
10 Mar 2024
Lead sponsor
Riphah International University
Diseases
Asthma
NCT number
NCT06869655

What you commit to

  • Study type: Interventional
  • Participants enrolled: 50
  • From 10 Mar 2024 to the primary completion date, 10 Mar 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Asthma patients whose condition require hospitalization asthmatic patients with physical limitation patients, with exercise-induced asthma, Asthma patients with heart dis¬ease with evidence of cardiovascular osteoarticular, inability to consent or cooperate, long-term, home oxygen therapy, active tuberculosis or other infectious disorders as well as stroke, are excluded

Who the study is looking for

  • Age range between 35 years to 50 years who must have a confirm diagnosis of asthma and FEV1% \>60% \& \<80%, both male and female with moderate asthma. Outpatients from regional medical Centre.

Age in the registry: 35 years to 50 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Gulab Devi Hospital
Coordinator of this site? Confirm its status
LahorePakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.